AUPH Aurinia Pharmaceuticals Inc. Stock Quote

AUPH [NASD]

Index	-	P/E	-	EPS (ttm)	-0.87	Insider Own	7.20%	Shs Outstand	128.12M	Perf Week	-1.86%
Market Cap	1.62B	Forward P/E	-	EPS next Y	-0.55	Insider Trans	-0.10%	Shs Float	116.08M	Perf Month	15.33%
Income	-	PEG	-	EPS next Q	-0.14	Inst Own	50.90%	Short Float	7.35%	Perf Quarter	-11.30%
Sales	50.12M	P/S	32.31	EPS this Y	-53.00%	Inst Trans	-	Short Ratio	2.36	Perf Half Y	-14.82%
Book/sh	3.22	P/B	3.93	EPS next Y	45.50%	ROA	-	Target Price	11.50	Perf Year	-18.50%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W Range	9.72 - 20.50	Perf YTD	-8.60%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-39.90%	Beta	-
Dividend %	-	Quick Ratio	-	Sales past 5Y	-	Gross Margin	-	52W Low	26.75%	ATR	0.75
Employees	294	Current Ratio	-	Sales Q/Q	172417.20%	Oper. Margin	-	RSI (14)	45.12	Volatility	3.69% 5.34%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	-	Profit Margin	-	Rel Volume	0.66	Prev Close	12.64
Shortable	Yes	LT Debt/Eq	-	Earnings	May 06 AMC	Payout	-	Avg Volume	3.62M	Price	12.32
Recom	1.70	SMA20	-6.06%	SMA50	-2.07%	SMA200	-12.17%	Volume	2,209,722	Change	-2.53%

Jan-25-21

Reiterated

H.C. Wainwright

Buy

$30 → $35

Nov-03-20

Reiterated

H.C. Wainwright

Buy

$34 → $28

Jun-17-20

Initiated

BTIG Research

Buy

$20

May-05-20

Initiated

Cowen

Outperform

Jan-10-20

Initiated

Jefferies

Buy

$27

Dec-16-19

Reiterated

H.C. Wainwright

Buy

$25 → $32

Mar-16-18

Reiterated

Cantor Fitzgerald

Overweight

$14 → $16

Feb-08-18

Initiated

RBC Capital Mkts

Outperform

Oct-30-17

Reiterated

H.C. Wainwright

Buy

$10 → $12

May-18-17

Reiterated

H.C. Wainwright

Buy

$12 → $10

Apr-11-17

Initiated

Cantor Fitzgerald

Overweight

$14

Mar-22-17

Reiterated

FBR & Co.

Outperform

$9 → $11

Dec-30-16

Reiterated

H.C. Wainwright

Buy

$10 → $8

Aug-17-16

Reiterated

H.C. Wainwright

Buy

$7 → $10

Jun-30-16

Initiated

H.C. Wainwright

Buy

May-08-15

Initiated

MLV & Co

Buy

Jun-14-21 06:05AM	Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors Business Wire
Jun-07-21 07:05PM	Aurinia Announces Results of the 2021 Annual General Meeting Business Wire
07:04AM	Aurinia Announces Additional Analysis of its AURORA 1 Phase 3 Study Data Presented at ERA-EDTA 2021 Congress Business Wire
May-27-21 06:05AM	Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference Business Wire
May-21-21 07:58AM	Aurinia's Lupkynis Shows Sustained Renal Response Rates In Lupus Nephritis Patients Benzinga
May-20-21 04:05PM	Aurinia To Present Supportive AURORA 2 Continuation Study Interim Analysis Demonstrating Long-Term Safety & Efficacy of LUPKYNIS (voclosporin) in Subjects with Lupus Nephritis Business Wire
May-19-21 10:00AM	2 Grossly Undervalued Biotech Stocks That Could Double Your Money Motley Fool
May-14-21 06:05AM	Aurinia Pharmaceuticals to Participate in Two Upcoming Investor Conferences Business Wire +8.76%
May-13-21 09:22AM	Is the Options Market Predicting a Spike in Aurinia (AUPH) Stock? Zacks
May-10-21 05:47PM	Better Days Are on the Horizon for Aurinia Stock, Says Analyst TipRanks
04:05PM	Aurinia Unveils Patient Navigation Grant Program to Address Access Barriers for Individuals Living with Lupus and Lupus Nephritis Business Wire
06:53AM	Aurinia Pharma's Stock Gains After Lupkynis Data From Late-Stage Lupus Nephritis Study Published In Lancet Benzinga
06:05AM	Aurinia Announces Publication of AURORA 1 Phase 3 Study Results with LUPKYNIS (voclosporin) in The Lancet Business Wire
May-06-21 07:45PM	Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Misses Revenue Estimates Zacks
05:33PM	Why Aurinia Pharmaceuticals Stock Is Crashing Today Motley Fool
04:05PM	Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights Business Wire
03:15PM	Aurinia Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Apr-28-21 06:30AM	Aurinia Pharmaceuticals to Release First Quarter 2021 Financial Results on May 6, 2021 Business Wire
Apr-26-21 06:59AM	Is AUPH Stock A Buy or Sell? Insider Monkey +5.04%
Apr-15-21 06:05AM	Aurinia Pharmaceuticals to Present at the Bloom Burton & Co. Healthcare Investor Conference Business Wire
Apr-08-21 07:38AM	Aurinia's Lupkynis Shows Treatment Benefit In Lupus Nephritis, Additional Efficacy Data Shows Benzinga
06:05AM	Aurinia Presents Data Demonstrating LUPKYNIS (voclosporin) Efficacy Across Lupus Nephritis Biopsy Classes at National Kidney Foundation 2021 Spring Clinical Meetings Business Wire
Mar-31-21 01:36AM	When Can We Expect A Profit From Aurinia Pharmaceuticals Inc. (TSE:AUP)? Simply Wall St.
Mar-15-21 08:52AM	3 Favorite Names With Exciting Potential TheStreet.com
06:05AM	Aurinia Announces Positive Cost-Effectiveness Assessment of LUPKYNIS (voclosporin) in Latest ICER Draft Evidence Report Business Wire
Mar-11-21 07:45AM	Aurinia Pharmaceuticals: Short-Term Trading of a Long-Term Favorite TheStreet.com
Mar-02-21 06:05AM	Aurinia Pharmaceuticals to Present at Three Upcoming March Investor Conferences Business Wire
Feb-25-21 12:00AM	Aurinia Pharmaceuticals Inc (AUPH) Q4 2020 Earnings Call Transcript Motley Fool
Feb-24-21 04:02PM	Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights Business Wire
02:30PM	Aurinia Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Feb-23-21 10:29AM	Earnings Preview: Aurinia Pharmaceuticals Benzinga -5.83%
Feb-18-21 06:05AM	Aurinia Pharmaceuticals to Present at the SVB Leerink 10th Annual Global Healthcare Conference Business Wire
Feb-17-21 06:05AM	Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2020 Financial Results on February 24, 2021 Business Wire
Feb-14-21 02:08AM	We're Not Worried About Aurinia Pharmaceuticals' (TSE:AUP) Cash Burn Simply Wall St.
Feb-11-21 05:30PM	Orea Reports that French Government has Announced Appeal of Court Decision to Renew the Montagne d'Or Mining Concessions CNW Group
Feb-01-21 07:45AM	Shark Bites: Anatomy of a Trade - Aurinia Pharmaceuticals TheStreet.com
Jan-27-21 11:05AM	Biotech Stock Roundup: Coronavirus Updates From REGN, MRNA, & Other Updates Zacks -8.91%
06:27AM	Here's Why Everybody's Talking About Aurinia Pharmaceuticals Stock Motley Fool
Jan-26-21 08:07AM	The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market Benzinga -5.93%
Jan-25-21 04:22PM	Why Aurinia Pharmaceuticals Stock Is Flying Today Motley Fool +26.04%
10:34AM	Aurinia (AUPH) Gets FDA Nod for Kidney Disorder Drug Lupkynis Zacks
06:53AM	Aurinias Kidney Disease Treatment Wins FDA Approval; Street Sees 78% Upside SmarterAnalyst
Jan-22-21 08:24PM	FDA Approves Aurinia Pharmaceuticals LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis Business Wire
Jan-11-21 09:56AM	Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options Zacks +5.37%
Jan-08-21 06:05AM	Aurinia Pharmaceuticals to Present at Two Upcoming Virtual Healthcare Conferences Business Wire
Jan-02-21 10:45AM	Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates Benzinga
Dec-30-20 11:08AM	My Top Six 2020 Stock Picks Gained an Average of 75% TheStreet.com
Dec-28-20 08:32AM	Aurinia (AUPH) Looks Good: Stock Adds 5.5% in Session Zacks
Dec-21-20 03:40PM	Is AUPH A Good Stock To Buy According To Hedge Funds? Insider Monkey
Dec-17-20 11:02AM	Adding to an Old Favorite and Taking Some Profits in Cannabis TheStreet.com -14.70%
08:10AM	The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut Benzinga
04:00AM	Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan Business Wire
Dec-16-20 07:15AM	The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal Benzinga
Dec-15-20 05:59PM	Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity Business Wire
03:00AM	Here's What Aurinia Pharmaceuticals Inc.'s (TSE:AUP) Shareholder Ownership Structure Looks Like Simply Wall St.
Dec-02-20 06:05AM	Aurinia Pharmaceuticals to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference Business Wire
Nov-29-20 06:44AM	Top 10 Healthcare Stocks To Buy for the Future Insider Monkey
Nov-20-20 05:00PM	Aurinia Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire +7.29%
Nov-12-20 04:05PM	Aurinia Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference Business Wire
Nov-11-20 08:45AM	Should You Buy Aurinia Pharmaceuticals (AUPH) Ahead of Earnings? Zacks
Nov-10-20 05:15PM	Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Lags Revenue Estimates Zacks
04:30PM	Aurinia Pharmaceuticals: Q3 Earnings Insights Benzinga
04:02PM	Aurinia Reports Third Quarter 2020 Financial Results and Recent Operational Highlights Business Wire
Nov-09-20 04:05PM	Aurinia Presents Integrated Time to Renal Response Data from the AURA-LV and AURORA Trials, along with Voclosporin Drug-Drug Interaction Data at ACR Convergence 2020 Business Wire
Nov-05-20 12:30PM	Aurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Nov-04-20 02:25PM	Biotech Stock Roundup: Gilead, Amgen, Vertex and Alexion Report Q3 Earnings & More Zacks
Nov-03-20 07:38AM	The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure Benzinga -9.87%
01:55AM	Aurinia Tanks 10% As Dry Eye Trial Fails To Reach Primary Endpoint SmarterAnalyst
Nov-02-20 04:05PM	Aurinia Announces Outcome of AUDREY Clinical Trial in Dry Eye Syndrome Business Wire
Oct-28-20 07:41AM	The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts Benzinga
Oct-27-20 04:05PM	Aurinia Announces European Investigator-Initiated Trial to Evaluate Antiviral Activity of Voclosporin in Kidney Transplant Recipients with COVID-19 Business Wire
Oct-22-20 04:15PM	Aurinia Presents Voclosporin Efficacy and Pharmacokinetic Data from Integrated Analysis of AURA-LV and AURORA Pivotal Trials at ASN Kidney Week 2020 Business Wire
Oct-16-20 06:28AM	Analysts Expect Breakeven For Aurinia Pharmaceuticals Inc. (TSE:AUP) Before Long Simply Wall St.
Oct-14-20 06:05AM	Aurinia Pharmaceuticals Announces Launch of Lupus Nephritis Disease-State Awareness Initiative for Healthcare Professionals, TimeIsNephrons.com Business Wire
Oct-05-20 01:30PM	Shark Bites: Positioning for a Positive Catalyst in Aurinia Pharmaceuticals TheStreet.com +6.84%
Oct-02-20 05:00PM	Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Sep-29-20 06:44PM	Aurinia Completes Final Patient Treatment in Dry Eye Study Zacks
Sep-28-20 06:05AM	Aurinia Completes Final Patient Treatment in AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for Dry Eye Syndrome Business Wire
Sep-16-20 03:26PM	Hedge Funds Cant Stop Buying Aurinia Pharmaceuticals Inc (AUPH) Insider Monkey
Sep-10-20 06:05AM	Aurinia Pharmaceuticals to Present at Three Upcoming Virtual Investor Conferences Business Wire
Sep-04-20 06:04PM	Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Aug-11-20 05:29PM	Recap: Aurinia Pharmaceuticals Q2 Earnings Benzinga
05:15PM	Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:02PM	Aurinia Reports Second Quarter 2020 Financial Results and Recent Operational Highlights Business Wire
Aug-04-20 12:30PM	Analysts Estimate Aurinia Pharmaceuticals (AUPH) to Report a Decline in Earnings: What to Look Out for Zacks
06:05AM	Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference Business Wire
Jul-30-20 06:05AM	Aurinia Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 11, 2020 Business Wire
Jul-28-20 12:33PM	Analysts Estimate Aurinia Pharmaceuticals (AUPH) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-27-20 10:15AM	Aurinia Closes US$200 Million Public Offering of Common Shares Business Wire
Jul-23-20 06:59PM	Why Aurinia Pharmaceuticals Dived by 16% on Thursday Motley Fool -16.27%
Jul-22-20 11:05PM	Aurinia Prices US$200 Million Public Offering of Common Shares Business Wire +15.06%
04:08PM	Aurinia Announces Public Offering of Common Shares Business Wire
11:31AM	Why Aurinia Pharmaceuticals Is Up Today Motley Fool
07:24AM	The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat Benzinga
04:03AM	Aurinia Pharma Surges 9% On Priority Review For Lupus Kidney Treatment SmarterAnalyst
Jul-21-20 05:27PM	Aurinia Announces U.S. Food and Drug Administration Acceptance of the Filing of New Drug Application and Priority Review for Voclosporin for the Treatment of Lupus Nephritis Business Wire
Jul-18-20 10:02AM	Aurinia Pharmaceuticals (TSE:AUP) Is In A Good Position To Deliver On Growth Plans Simply Wall St.
Jul-15-20 01:15PM	Steven Cohen Homes in on Otonomy GuruFocus.com
Jul-12-20 08:15PM	Did Hedge Funds Make The Right Call On Aurinia Pharmaceuticals Inc (AUPH) ? Insider Monkey
Jun-22-20 06:05AM	Aurinia Completes Patient Enrollment Into the AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for the Treatment of Dry Eye Syndrome Business Wire

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MacKay-Dunn R. Hector	Director	May 12	Buy	11.27	3,000	33,804	6,000	May 13 04:17 PM
Martin Michael Robert	Chief Business Officer	May 11	Option Exercise	3.02	20,000	60,400	221,861	May 12 04:30 PM
Huizinga Robert Bindert	Ex Vice President of Research	May 11	Option Exercise	3.02	40,000	120,800	143,592	May 11 05:22 PM
Miller Joseph M	Chief Financial Officer	May 11	Buy	9.74	1,000	9,740	1,000	May 11 04:53 PM
MacKay-Dunn R. Hector	Director	May 11	Buy	11.15	1,500	16,725	3,000	May 13 04:17 PM
Donley Matthew Maxwell	Ex VP, Intern'l Operations	May 11	Buy	10.07	9,900	99,739	9,900	May 12 04:34 PM
Greenleaf Peter	Chief Executive Officer	May 11	Buy	10.71	5,125	54,891	13,453	May 12 04:32 PM
Leversage Jill	Director	May 11	Buy	10.96	2,500	27,389	3,700	May 12 04:28 PM
Solomons Neil	Chief Medical Officer	Mar 12	Option Exercise	3.02	40,000	120,800	227,299	Mar 15 04:36 PM
Solomons Neil	Chief Medical Officer	Mar 12	Sale	13.49	40,000	539,600	187,299	Mar 15 04:36 PM
MILNE GEORGE M JR	Director	Mar 05	Buy	13.00	5,000	65,000	45,000	Mar 09 04:25 PM
Hayden Michael R	Director	Jan 29	Option Exercise	5.79	95,000	550,100	95,000	Feb 02 03:18 PM
Leversage Jill	Director	Jan 29	Buy	16.03	400	6,412	400	Feb 02 03:22 PM
Leversage Jill	Director	Jan 29	Buy	16.03	1,200	19,236	1,200	Feb 02 03:22 PM
Robertson Stephen P.	EVP, General Counsel	Jan 28	Buy	16.14	900	14,526	2,720	Jan 29 12:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience